Three months following the first closing of its Series C financing, iThera Medical completed a second closing with Occident Ventures, BayBG and Falk…

We would like to thank all our clients, colleagues and partners in technology transfer, research and industry for the enjoyable and productive…

Agreement with Max Delbrück Center Provides Access to Broad Intellectual Property Portfolio of Unique Humanized Antibody Fragments and Antigen-Binding…

Following the successful completion of a Phase I trial with its cardioprotective lead candidate OMT-28, OMEICOS has now closed a Series C financing…

This year’s technology transfer award from Braunschweig’s Chamber of Industry and Commerce goes to scientists at the Helmholtz Centre for Infection…

iThera Medical, a spin-off from the Helmholtz Zentrum München, has closed series C financing with new investors FLUXUNIT, the corporate venture…

Ascenion’s partner institute, the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), has joined forces with the…

In 2017 many exceptional projects from our partners reached important milestones, amongst them potential diagnostics and therapeutics as well as…

The European Commission has granted approval for Amgen’s BLINCYTO® (blinatumomab) for the treatment of pediatric patients with certain forms of B cell…

Drug developer Berlin Cures announced the successful completion of its Phase 1 study of its lead candidate BC 007 for the treatment of cardiomyopathy.…

Ascenion’s portfolio company OMEICOS reported positive Phase I data for its lead candidate OMT-28, a small molecule with strong anti-arrhythmic and…

BioFIT is a partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life…

Phase I study initiated with candidate against multidrug-resistant germs 

6 June 2018, Munich – The Leibniz Institute for Natural Product Research…

In April, the members of the rapidly growing TechnologieAllianz e.V. teamed up with founders, investors, scientists and politicians for the 3rd…

This year’s BioVaria was the event in 2018 for early-stage, life-science European startups to connect with investors, with a record number of company…

Prague, Czech Republic

Ankara, Turkey

Cologne, Germany